Integer - ITGR Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.

2 brokerages have issued 12-month target prices for Integer's stock. Their ITGR share price forecasts range from $85.00 to $90.00. On average, they expect the company's stock price to reach $87.00 in the next twelve months. This suggests a possible upside of 18.1% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $68.46 on January 1st, 2023. Since then, ITGR shares have increased by 7.6% and is now trading at $73.64.
View the best growth stocks for 2023 here.

Integer saw a increase in short interest in February. As of February 15th, there was short interest totaling 1,690,000 shares, an increase of 184.7% from the January 31st total of 593,600 shares. Based on an average daily volume of 274,700 shares, the days-to-cover ratio is currently 6.2 days. Currently, 5.2% of the company's stock are sold short.
View Integer's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our ITGR earnings forecast.

Integer Holdings Co. (NYSE:ITGR) released its quarterly earnings data on Thursday, February, 16th. The medical equipment provider reported $1.11 EPS for the quarter, beating the consensus estimate of $1.05 by $0.06. The medical equipment provider earned $372.42 million during the quarter, compared to the consensus estimate of $371 million. Integer had a net margin of 4.82% and a trailing twelve-month return on equity of 9.42%. The business's revenue was up 19.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.99 EPS.

ETFs with the largest weight of Integer (NYSE:ITGR) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), SPDR S&P 600 Small CapValue ETF (SLYV), iShares S&P Small-Cap 600 Value ETF (IJS), Timothy Plan US Small Cap Core ETF (TPSC), Global X Aging Population ETF (AGNG), Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS) and SPDR S&P 600 Small Cap ETF (SLY).

Integer updated its FY 2023 earnings guidance on Monday, February, 20th. The company provided earnings per share guidance of $4.00-$4.30 for the period, compared to the consensus EPS estimate of $4.23. The company issued revenue guidance of $1.47 billion-$1.50 billion, compared to the consensus revenue estimate of $1.49 billion.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Franklin Resources Inc. (7.73%), Dimensional Fund Advisors LP (6.39%), Earnest Partners LLC (3.62%), Victory Capital Management Inc. (3.49%), Victory Capital Management Inc. (3.47%) and Victory Capital Management Inc. (3.45%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $73.64.

Integer (NYSE:ITGR) has a market capitalization of $2.45 billion and generates $1.38 billion in revenue each year. The medical equipment provider earns $66.38 million in net income (profit) each year or $1.98 on an earnings per share basis.

The company employs 10,000 workers across the globe.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.